BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24976477)

  • 1. Current and future perspectives on drug-eluting bioresorbable coronary scaffolds.
    Ielasi A; Tespili M
    Future Cardiol; 2014 May; 10(3):409-20. PubMed ID: 24976477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Looking into the future with bioresorbable vascular scaffolds.
    Costopoulos C; Naganuma T; Latib A; Colombo A
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1407-16. PubMed ID: 24138526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioresorbable scaffolds: current knowledge, potentialities and limitations experienced during their first clinical applications.
    Bourantas CV; Onuma Y; Farooq V; Zhang Y; Garcia-Garcia HM; Serruys PW
    Int J Cardiol; 2013 Jul; 167(1):11-21. PubMed ID: 22748288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioresorbable scaffolds for the treatment of coronary artery disease: current status and future perspective.
    Kraak RP; Grundeken MJ; Koch KT; de Winter RJ; Wykrzykowska JJ
    Expert Rev Med Devices; 2014 Sep; 11(5):467-80. PubMed ID: 25087771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.
    Rizik DG; Hermiller JB; Kereiakes DJ
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):21-30. PubMed ID: 27797464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which patients could benefit the most from bioresorbable vascular scaffold implant: from clinical trials to clinical practice.
    Latib A; Costopoulos C; Naganuma T; Colombo A
    Minerva Cardioangiol; 2013 Jun; 61(3):255-62. PubMed ID: 23681128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioresorbable vascular scaffolds in left main coronary artery disease.
    Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives.
    Kitabata H; Waksman R; Warnack B
    Cardiovasc Revasc Med; 2014 Mar; 15(2):109-16. PubMed ID: 24684760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current perspectives on the role of bioresorbable scaffolds in the management of coronary artery disease.
    Dziewierz A; Dudek D
    Kardiol Pol; 2018; 76(7):1043-1054. PubMed ID: 30251247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paving the way to a bioresorbable technology: Development of the absorb BRS program.
    Perkins LE; Kossuth MB; Fox JC; Rapoza RJ
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):1-9. PubMed ID: 27797462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioresorbable vascular scaffold in patients with complex coronary artery disease.
    Tamburino CI; Capranzano P; Longo G; Immè S; Tamburino G; Scalia M; Condorelli A; Francaviglia B; LA Manna A; Sgroi C; Grasso C; DI Salvo ME; Capodanno D; Tamburino C
    Minerva Cardioangiol; 2016 Aug; 64(4):481-6. PubMed ID: 27128353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latest generation stents: is it time to revive the bioresorbable scaffold?
    Buono A; Ielasi A; Colombo A
    Minerva Cardioangiol; 2020 Oct; 68(5):415-435. PubMed ID: 32643897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioresorbable scaffolds for coronary artery disease: current status and future prospective.
    Zhang Y; Gao R; Xu B; Cummins P; Serruys PW
    Chin Med J (Engl); 2014; 127(6):1141-8. PubMed ID: 24622448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioresorbable scaffolds: talking about a new interventional revolution [corrected].
    Hassell ME; Grundeken MJ; Delewi R; Wykrzykowska JJ; Piek JJ
    Minerva Cardioangiol; 2013 Apr; 61(2):165-79. PubMed ID: 23492600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention.
    Tenekecioglu E; Farooq V; Bourantas CV; Silva RC; Onuma Y; Yılmaz M; Serruys PW
    BMC Cardiovasc Disord; 2016 Feb; 16():38. PubMed ID: 26868826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The bioresorbable coronary scaffold].
    Hassell ME; van de Hoef TP; Damman P; Delewi R; Serruys PW; Piek JJ
    Ned Tijdschr Geneeskd; 2012; 156(36):A4994. PubMed ID: 22951133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioresorbable Scaffolds for Coronary Artery Disease.
    Nathan A; Kobayashi T; Kolansky DM; Wilensky RL; Giri J
    Curr Cardiol Rep; 2017 Jan; 19(1):5. PubMed ID: 28108898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unmet needs: How future technologies will address current limitations of bioresorbable scaffold technology.
    Abizaid A; Ribamar Costa J
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):54-59. PubMed ID: 27797459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of bioresorbable scaffolds: hype or hope?
    Tan HC; Ananthakrishna R
    Singapore Med J; 2017 Sep; 58(9):512-515. PubMed ID: 27868135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioresorbable scaffolds in peripheral arterial disease.
    Kassimis G; Spiliopoulos S; Katsanos K; Tsetis D; Krokidis ME
    Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):443-50. PubMed ID: 24650312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.